Volume 29, Number 11—November 2023
Dispatch
Hepatitis C Virus Elimination Program among Prison Inmates, Israel
Lihi Eisen1
, Zohar Mor1, Miriam Madar, Ron Rabinovitch, Yuval Dadon, Rivka Sheffer, Ehud Kaliner, and Liav Goldstein
, Zohar Mor1, Miriam Madar, Ron Rabinovitch, Yuval Dadon, Rivka Sheffer, Ehud Kaliner, and Liav Goldstein
Table 2
Comparison between participants with HCV-positive and HCV-negative serology in a hepatitis C virus elimination program among high-risk prison inmates, Israel*
| Characteristics | HCV-positive, n = 379 | HCV-negative, n = 1,372 | p value | Multivariate analysis |
|
|---|---|---|---|---|---|
| OR (95% CI) | p value | ||||
| Sex | |||||
| M | 367 (96.8) | 1,334 (97.2) | 0.8 | ||
| F | 12 (3.2) | 37 (2.7) | |||
| Transgender |
0 |
1 (0.1) |
|||
| Mean age, y (SD) |
47.6 (9.3) |
39.9 (12.4) |
<0.01 |
1.06 (1.05–1.08) |
<0.01 |
| Marital status | |||||
| Married | 77 (20.3) | 375 (27.33) | <0.01 | Referent | <0.01 |
| Nonmarried† | 299 (78.9) | 983 (71.65) | 1.7 (1.2–2.4) | ||
| Data not available |
3 (0.8) |
14 (1.02) |
|||
| Education level, did not complete high school |
299 (78.9) |
1,059 (77.2) |
0.4 |
||
| Previously incarcerated‡ | 342 (90.2) | 1,129 (82.2) | <0.01 | ||
| Mean number of imprisonments (SD) |
11.6 (8.8) |
7.3 ± 6.5 |
<0.01 |
1.07 (1.05–1.09) |
<0.01 |
| Smoker |
324 (85.5) |
1,118 (81.5) |
0.07 |
||
| Alcohol user |
33 (8.7) |
169 (12.3) |
0.05 |
||
| Risk criteria | |||||
| Country of birth | |||||
| Former Soviet Union and Romania | 201 (53.0) | 450 (32.8) | <0.01 | 7.4 (5.4–10.3) | |
| Israel | 157 (41.4) | 719 (52.4) | Referent | <0.01 | |
| West Bank and Gaza Strip | 9 (2.4) | 106 (7.7) | |||
| Other countries | 9 (2.4) | 71 (5.2) | |||
| Data not available |
3 (0.8) |
26 (1.9) |
|||
| Drug use | |||||
| No drug use | 53 (14.0) | 318 (23.2) | <0.01 | Referent | <0.01 |
| Non–IV drug use | 176 (46.4) | 877 (63.9) | 5.4 (3.5–8.4) | ||
| IV drug use |
150 (39.6) |
177 (12.9) |
12.8 (7.9–20.7) |
||
| HIV infection |
11 (2.9) |
7 (0.5) |
<0.01 |
NA |
NS |
| Hepatitis B virus infection | 31 (8.1) | 40 (2.9) | <0.01 | 3.8 (2.0–7.3) | <0.01 |
*Values indicate no. (%) unless otherwise indicated. IV, intravenous; NA, not applicable; NS, not significant. †Includes single, divorced, and widowed. ‡This variable was not included in the multivariate analysis because it is collinear with number of imprisonments.
1These authors contributed equally to this article.
Page created: September 29, 2023
Page updated: October 23, 2023
Page reviewed: October 23, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.